A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the ...
A rare intracranial brain-recording study revealed that tirzepatide, a GLP-1 and GIP receptor agonist, temporarily silences craving-related neural activity in a key reward circuit of the brain.
Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback